JAGSONPAL PHARMACEUTICALS
|
The Current P/S Ratio of JAGSONPAL PHARMACEUTICALS is 5.17.
| Share Price | ₹230.5 | Jul 29,2026 |
| Market Cap | ₹1,519.0 Cr | |
| Sales-TTM | ₹293.8 Cr | TTM-Standalone Results |
| Price/Sales | 5.17x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of JAGSONPAL PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹1,519.0 Cr] as on Jul 29,2026
(/) Sales [ ₹293.8 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 5.17x ]
Thus, for JAGSONPAL PHARMACEUTICALS , the investors are currently willing to pay '5.17 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of JAGSONPAL PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of JAGSONPAL PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of JAGSONPAL PHARMACEUTICALS
PS Ratio Performance Analysis for JAGSONPAL PHARMACEUTICALS
- JAGSONPAL PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 3.40x.
- JAGSONPAL PHARMACEUTICALS 's operated at median p/e ratio of 3.55x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, JAGSONPAL PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 5.34x.
- JAGSONPAL PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2021 of 1.11x.
How does JAGSONPAL PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| JAGSONPAL PHARMACEUTICALS | 293.8 | 5.17 | 1,519.0 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 58,462.0 | 8.17 | 477,408.0 |
| DIVIS LABORATORIES LTD | 10,560.0 | 19.59 | 206,906.0 |
| TORRENT PHARMACEUTICALS LTD | 13,980.0 | 13.27 | 185,521.0 |
| CIPLA LTD | 28,324.4 | 4.20 | 119,032.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 2.87 | 95,420.1 |
| MANKIND PHARMA LTD | 14,277.6 | 7.50 | 107,071.0 |
| LUPIN LTD | 27,958.0 | 4.01 | 112,013.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 4.12 | 111,960.0 |
| AUROBINDO PHARMA LTD | 33,653.1 | 2.72 | 91,531.1 |
| LAURUS LABS LTD | 7,269.6 | 13.24 | 96,264.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs JAGSONPAL PHARMACEUTICALS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.72x |
| Max industry PS | 19.59x |
| Median industry PS | 5.17x |
| Average industry PS | 7.72x |
You may also like the below Video Courses